Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial

Chronic kidney disease and type 2 diabetes are independently associated with heart failure (HF), a leading cause of morbidity and mortality. In the FIDELIO-DKD (Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease) and FIGARO-DKD (Finerenone in Reducing Cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippatos, Gerasimos, Anker, Stefan D., Agarwal, Rajiv, Ruilope, Luis M., Rossing, Peter, Bakris, George L., Tasto, Christoph, Joseph, Amer, Kolkhof, Peter, Lage, Andrea, Pitt, Bertram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812430/
https://www.ncbi.nlm.nih.gov/pubmed/34775784
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812430/
https://www.ncbi.nlm.nih.gov/pubmed/34775784
http://dx.doi.org/10.1161/CIRCULATIONAHA.121.057983

Ejemplares similares